Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 7/20 | 0.45 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA9 | Q16790 | 4/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.43 |
| ▸ | CXCR1 | P25024 | 4/20 | 0.43 |
| ▸ | CXCR2 | P25025 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3432503 | 0.83 | ERN1 (0.48) | PTGS2CA1CA2CA9CA12 | |
| Acetic Acid SCHEMBL28992429 | 0.77 | THRB (0.48) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7102472 | 0.77 | PTGS2 (0.47) | PTGS2CA1CA2CA9CA12 | |
| SCHEMBL28195583 | 0.77 | PTGS2 (0.40) | PTGS2PTGS1CXCR1CXCR2MAPT | |
| SCHEMBL4175255 | 0.77 | CA1 (0.50) | PTGS2CA1CA2CA9CA12 | |
| SCHEMBL490576 | 0.77 | PTGS2 (0.47) | PTGS2CA1CA2CA9CA12 | |
| SCHEMBL19444465 | 0.76 | CA2 (0.48) | CA1CA2CA9CA12CA7 | |
| SCHEMBL15645990 | 0.76 | CES2 (0.47) | PTGS2PTGS1CXCR1CXCR2MAPT | |
| SCHEMBL153695 | 0.76 | PTGS2 (0.59) | PTGS2CA1CA2CA9CA12 | |
| SCHEMBL15645912 | 0.76 | CES2 (0.47) | PTGS2PTGS1CXCR1CXCR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117586497-B | Preparation method of printing ink based on amino-terminated hyperbranched polyamide | 江苏众立生包装科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117586497-A | Preparation method of printing ink based on amino-terminated hyperbranched polyamide | 江苏众立生包装科技有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117586497-B | Preparation method of printing ink based on amino-terminated hyperbranched polyamide | 江苏众立生包装科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117586497-A | Preparation method of printing ink based on amino-terminated hyperbranched polyamide | 江苏众立生包装科技有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20210139521-A1 | DIARYL TREHALOSE COMPOUNDS AND USES THEREOF | THE UNIV OF MONTANA (US) | 2021-05-13 | — | — | US | disclosed |
| CN-1412181-A | Carboxylic acid derivatives inhibiting the binding of integrins to their receptors | TEXAS BIOTECHNOLOGIES CORP (US) | 2003-04-23 | — | — | CN | disclosed |
| CN-1360498-A | Carboxylic acid derivs. that inhibit binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORP (US) | 2002-07-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139521-A1 | DIARYL TREHALOSE COMPOUNDS AND USES THEREOF | TREH, STT3B, DDOST | PTGS2 4096/4885CA1 1399/4885CA2 1958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.